北京商报讯（记者 张君花）1月20日，安正时尚发布业绩预告称，预计2025年亏损1.3亿元到2.1亿元， 报告期内，控股子公司礼尚信息新拓展业务销售未达预期，商誉出现减值迹象。公司结合实际经营情况 及电商服务行业市场变化等因素，按照相关会计准则对存在减值迹象的相关资产或资产组进行了减值测 试，拟计提商誉减值约6300万元。报告期内，公司按照相关会计准则对存货进行了减值测试，拟计提存 货跌价损失约1.07亿元（同比增加约3300万元，主要系礼尚信息新拓展项目存货跌价增加所致）。 ...

2024年4月公司完成了石家庄宇讯电子有限公司及北京海为科技有限公司的收购。本年度，结合当前的 经营状况以及对未来经营情况的分析预测，公司管理层初步判断该商誉出现减值迹象。根据企业会计准 则及公司会计政策等相关规定，2025年度预计计提商誉减值准备的金额约2,800.00万元。最终商誉减值 准备计提金额，需依据评估机构出具的商誉减值测试评估报告以及会计师事务所审计确定。 理工导航(688282.SH)发布2025年年度业绩预亏公告，预计2025年年度实现归属于母公司所有者净亏损 600万元至1200万元，与上年同期相比(法定披露数据)，将减少146.81万元到746.81万元，同比增亏 32.40%到164.79%。 公司与北京盈想东方科技股份有限公司(以下简称"盈想东方")因买卖合同纠纷事宜向北京市昌平区人民 法院提起诉讼，并于报告期内收到北京市昌平区人民法院出具的民事判决书。根据民事判决书及盈想东 方的信用状况进行判断，本着谨慎性原则，公司对应收款项和存货计提了单项减值。 ...

智通财经APP讯，理工导航(688282.SH)发布2025年年度业绩预亏公告，预计2025年年度实现归属于母 公司所有者净亏损600万元至1200万元，与上年同期相比(法定披露数据)，将减少146.81万元到746.81万 元，同比增亏32.40%到164.79%。 2024年4月公司完成了石家庄宇讯电子有限公司及北京海为科技有限公司的收购。本年度，结合当前的 经营状况以及对未来经营情况的分析预测，公司管理层初步判断该商誉出现减值迹象。根据企业会计准 则及公司会计政策等相关规定，2025年度预计计提商誉减值准备的金额约2,800.00万元。最终商誉减值 准备计提金额，需依据评估机构出具的商誉减值测试评估报告以及会计师事务所审计确定。 公司与北京盈想东方科技股份有限公司(以下简称"盈想东方")因买卖合同纠纷事宜向北京市昌平区人民 法院提起诉讼，并于报告期内收到北京市昌平区人民法院出具的民事判决书。根据民事判决书及盈想东 方的信用状况进行判断，本着谨慎性原则，公司对应收款项和存货计提了单项减值。 ...

Core Viewpoint - The company, Electric Soul Network (603258.SH), anticipates a net loss attributable to shareholders of the parent company ranging from 160 million to 230 million yuan for the fiscal year 2025 due to significant declines in game recharge revenue from its wholly-owned subsidiary, Xiamen Youdong Network Technology Co., Ltd. [1] Group 1 - The primary reason for the expected loss is the substantial decrease in game recharge revenue from the acquired subsidiary, which has significantly impacted the company's profits [1] - The company is also facing notable impairment of goodwill, with the expected amount of goodwill impairment provision increasing significantly year-on-year, subject to evaluation and audit by intermediaries [1] - Additionally, the decline in revenue from some existing games has further adversely affected the company's performance [1]

Core Viewpoint - The company is actively managing the impact of commodity price fluctuations, particularly copper prices, on its product costs through hedging strategies and is expanding its production capacity to meet increasing demand in the domestic and international markets. Group 1: Commodity Price Impact - Fluctuations in commodity prices, especially copper, do affect the company's product costs, but the overall impact is currently manageable [2] - The company employs copper futures hedging to mitigate the effects of copper price volatility and is reviewing its hedging strategies to better align with business needs [2] Group 2: Production Capacity and Orders - The new transformer workshop and equipment are being installed, tested, and gradually entering mass production, with the ability to meet customer delivery requirements [3] - The company will regularly review its production capacity based on expected order volumes and delivery timelines to determine if further expansion is necessary [4] Group 3: Market Demand and Expansion - The State Grid's investment plan during the "14th Five-Year Plan" period is set to reach a historical high, indicating strong demand in the domestic market, particularly for renewable energy [6] - The joint venture with Al Sharhan Energy in Saudi Arabia is a strategic move to address local customer needs, and the company maintains a cautious yet open approach to overseas factory investments [6] Group 4: Goodwill Assessment - The company has engaged a qualified assessment agency to evaluate potential goodwill impairment related to Xincheng Carbon Energy, with results to be disclosed in the annual report [8]

Core Viewpoint - The company Fengfan Co., Ltd. expects a significant increase in net losses for the year 2025, projecting a net profit attributable to the parent company of between -380 million to -320 million yuan, which represents a decrease of 4.11 billion to 4.71 billion yuan compared to the previous year's profit of 91.29 million yuan, indicating a year-on-year loss increase of 450.54% to 516.26% [1] Financial Performance - The company anticipates a non-recurring net profit of between -450 million to -380 million yuan, which is a decrease of 128 million to 198 million yuan compared to the previous year's non-recurring net profit of -25.2 million yuan, reflecting a year-on-year loss increase of 50.78% to 78.55% [1] Business Challenges - The primary reasons for the anticipated poor performance are overcapacity in the photovoltaic business and declining prices, leading to an expected goodwill impairment of approximately 339 million yuan for the year [1]

Core Viewpoint - Dongning Bio has submitted its listing application for the third time, aiming to provide comprehensive solutions in the life sciences sector, focusing on bioprocessing and laboratory products and services [1][3]. Financial Performance - Revenue for Dongning Bio during the reporting periods (2023 to 2025) was 814.08 million yuan, 842.88 million yuan, and 657.75 million yuan, respectively, with profits of -315 million yuan, -27.5 million yuan, and 14.26 million yuan, indicating a recent turnaround to profitability [3][4]. - The bioprocessing solutions segment accounted for 77% of total revenue in 2023, with reagents and consumables being the primary revenue driver, contributing 44.1%, 47%, and 55.4% in respective periods [3][4]. Business Segments - The company operates two main business lines: bioprocessing solutions and laboratory products and services, with the former being the larger contributor to revenue [1][3]. - The overseas revenue doubled in the first three quarters of 2025, rising from 53.8 million yuan to 112.41 million yuan, increasing its share of total revenue from 9.8% to 17.1% [5][6]. Major Clients and Shareholders - WuXi Biologics, a major shareholder with a 19.75% stake, is also the largest client, contributing 14.9%, 10.9%, and 12.1% of total revenue during the reporting periods [8][10]. - Revenue from the top five clients accounted for 31.1%, 23.9%, and 32.0% of total revenue, indicating a reliance on a concentrated client base [8]. Acquisitions and Goodwill - Since 2020, Dongning Bio has acquired several companies in the bioprocessing and laboratory services sector, leading to a goodwill value of 843 million yuan as of September 30, 2025, which may face impairment risks [10][11]. - The company must estimate future cash flows from acquired subsidiaries to assess goodwill impairment, which could negatively impact financial conditions if assumptions are not met [13].

Core Viewpoint - The company, Changyuan Technology Group Co., Ltd. (ST Changyuan), is forecasting a significant net loss for the year 2025, with expected losses ranging from 1.45 billion to 1.08 billion yuan, indicating a deteriorating financial performance compared to the previous year [2]. Group 1: Financial Performance - The projected net profit attributable to shareholders for 2025 is expected to be between -1.45 billion and -1.08 billion yuan, with the net profit excluding non-recurring gains and losses estimated between -1.15 billion and -800 million yuan [2]. - In comparison, the company's total profit for 2024 was -945.32 million yuan, with a net profit attributable to shareholders of -978.10 million yuan, and a net profit excluding non-recurring gains and losses of -667.47 million yuan, resulting in an earnings per share of -0.74 yuan [2]. Group 2: Reasons for Expected Loss - The primary reasons for the anticipated losses in 2025 include both operational and non-operational factors. The company's main business focuses on smart grid equipment and energy internet technology services, with revenue expected to remain stable compared to the previous year [3]. - The company plans to recognize impairment losses on goodwill and asset groups related to the acquisition of Zhuhai Yuntai Li, due to indications of goodwill impairment. The impairment and fair value loss on related assets are estimated to be between 600 million and 850 million yuan, subject to confirmation by auditing and evaluation agencies [3]. - Non-operational losses are expected to increase, with a projected decrease in investment income of approximately 400 million yuan compared to the previous year, primarily due to a loss of about 282 million yuan from the sale of a 25% stake in Changyuan Electronics [3]. Group 3: Legal Risks - The company has been notified of a civil lawsuit filed by its major shareholder, Zhuhai Gree Financial Investment Management Co., Ltd., and its concerted party, Zhuhai Free Trade Zone Jinnuo Xintai Trading Co., Ltd., regarding securities false statement liability, with an involved amount of approximately 413 million yuan. The impact of this lawsuit on the company's net profit for 2025 remains highly uncertain [4].

Core Viewpoint - The company expects to report a significant net loss in 2025 due to impairment related to its investment in the French joint venture HCo, despite projecting a substantial increase in net profit when excluding this impact [1][2] Group 1: Financial Projections - The company anticipates achieving approximately 6.35 billion yuan in revenue for 2025 [1] - The expected net loss attributable to shareholders for 2025 is projected to be between 178 million yuan and 356 million yuan [1] - After excluding the impact of the impairment, the company forecasts a net profit attributable to the parent company of between 260 million yuan and 318 million yuan for 2025 [1] Group 2: Impairment and Investment Impact - The impairment is primarily due to the acquisition of StHubert and its sales company ValleItalia, which resulted in a 49% stake held by the company in HCo [1] - The anticipated impairment loss on long-term equity investments is estimated to be between 496 million yuan and 616 million yuan [1] - The company expects a significant increase in net profit growth of 374% to 480% year-on-year for 2025 when excluding the impairment effects [2] Group 3: Operational Quality Improvement - The company projects a substantial increase in its net profit excluding non-recurring items, with an expected growth of 705% to 899% year-on-year for 2025 [2] - This indicates a significant improvement in the actual operational quality of the company [2]

Core Viewpoint - The company, China Boton (03318), announced a potential impairment loss of approximately RMB 750 million for its tobacco flavoring business as of December 31, 2025, due to reduced revenue from self-developed tobacco flavoring and a deteriorating overall market environment [1] Financial Impact - The estimated impairment loss may lead to a loss attributable to equity holders of the company for the year ending December 31, 2025 [1] Business Performance - The decline in revenue for the tobacco flavoring business is attributed to both the company's own product development and adverse market conditions [1]